Biospectal
Founded 2017 · 5 employees on LinkedIn · 3 known investors
Find your way into Biospectal
Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.
Investors · 3
Also in the syndicate · 1
SeedLinklead
Funding
SEC filings, press & company announcements$4.3M disclosed across 1 of 2 rounds · 2021
- Undisclosed amountSeed FundingJul 2021
SeedLink (lead)
Source ↗ - $4.3MraisedJul 2021 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Biospectal do?
- Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.
- Who are Biospectal's investors?
- Biospectal's investors include AEON Foundry, Privilège Ventures.
- How much funding has Biospectal raised?
- Biospectal has disclosed $4.3M raised across 1 of its 2 known rounds.